Low-density lipoprotein cholesterol and atrial fibrillation; A Mendelian randomization study using UK-Biobank data

ABSTRACT Objectives We used data from UK-Biobank that were linked with Hospital Episode Statistics and Office for National Statistics to assess the relationship between low-density lipoprotein cholesterol (LDL-C) and atrial fibrillation (AF). In this study, we applied Mendelian randomization in ord...

Full description

Bibliographic Details
Main Authors: Michail Katsoulis, Spiros Denaxas, Riyaz Patel, Harry Hemingway
Format: Article
Language:English
Published: Swansea University 2017-04-01
Series:International Journal of Population Data Science
Online Access:https://ijpds.org/article/view/322
id doaj-b24960aeed9b43908e8be551f5c31087
record_format Article
spelling doaj-b24960aeed9b43908e8be551f5c310872020-11-24T23:56:09ZengSwansea UniversityInternational Journal of Population Data Science2399-49082017-04-011110.23889/ijpds.v1i1.322322Low-density lipoprotein cholesterol and atrial fibrillation; A Mendelian randomization study using UK-Biobank dataMichail Katsoulis0Spiros Denaxas1Riyaz Patel2Harry Hemingway3UCL/ Farr Institute of Health Informatics ResearchUCL/ Farr Institute of Health Informatics ResearchUCL/ Farr Institute of Health Informatics ResearchUCL/ Farr Institute of Health Informatics ResearchABSTRACT Objectives We used data from UK-Biobank that were linked with Hospital Episode Statistics and Office for National Statistics to assess the relationship between low-density lipoprotein cholesterol (LDL-C) and atrial fibrillation (AF). In this study, we applied Mendelian randomization in order to find out whether there is a causal effect of LDL-C to AF. Approach We used data from the UK Biobank (~500,000 subjects) which is linked with electronic health records. At baseline (2006-2010), participants from across the UK took part in this project. They have undergone measures, provided blood, urine and saliva samples for future analysis, detailed information about themselves and agreed to have their health followed. Information in relation to the development of atrial fibrillation was derived from a) the enrollment of the participants (self-reported events), b) their hospitalization before and after their recruitment to UK-Biobank (confirmed events from Hospital Episode Statistics) and c) the death certificates [confirmed events from Office for National Statistics]. We also used genetic data from the analyses of the participants’ blood sample that have been stored. We used Mendelian randomization to capture the effect of LDL-C to AF. As instruments, we used a genetic predisposition risk score (GPRs) for LDL-C, which was created as a weighted sum of the 18 most significant SNPs related to LDL-C, as there were documented in Global Lipid Consortium, in 18 out of 22 chromosomes. We ran a logistic regression model, using AF as outcome and GPRs as exposure. Results Our final sample consisted of 144,092 individuals, for which we have valid information for their genetic data. The AF cases in this sample were 3207, most of which were identified from Hospital Episode Statistics (hospitalization of the participants). From the Mendelian randomization study, from our preliminary results, we found a weak positive relationship between GPRs and AF, when we did not adjust for any covariate [OR per one unit increase of GPRs=1.08, 95% CI= (0.95-1.22)] and results remained practically the same when we adjusted for age and sex [OR=1.09, 95% CI= (0.96-1.24 )]. Conclusion We observed a weak positive association between LDL-C and AF in this study. This is the first Mendelian randomization approach that focuses on this relationship. More Mendelian randomization studies should be performed in order to identify the causal effect of LDL-C to AF. The use of electronic health records will facilitate the conduction of similar studies.https://ijpds.org/article/view/322
collection DOAJ
language English
format Article
sources DOAJ
author Michail Katsoulis
Spiros Denaxas
Riyaz Patel
Harry Hemingway
spellingShingle Michail Katsoulis
Spiros Denaxas
Riyaz Patel
Harry Hemingway
Low-density lipoprotein cholesterol and atrial fibrillation; A Mendelian randomization study using UK-Biobank data
International Journal of Population Data Science
author_facet Michail Katsoulis
Spiros Denaxas
Riyaz Patel
Harry Hemingway
author_sort Michail Katsoulis
title Low-density lipoprotein cholesterol and atrial fibrillation; A Mendelian randomization study using UK-Biobank data
title_short Low-density lipoprotein cholesterol and atrial fibrillation; A Mendelian randomization study using UK-Biobank data
title_full Low-density lipoprotein cholesterol and atrial fibrillation; A Mendelian randomization study using UK-Biobank data
title_fullStr Low-density lipoprotein cholesterol and atrial fibrillation; A Mendelian randomization study using UK-Biobank data
title_full_unstemmed Low-density lipoprotein cholesterol and atrial fibrillation; A Mendelian randomization study using UK-Biobank data
title_sort low-density lipoprotein cholesterol and atrial fibrillation; a mendelian randomization study using uk-biobank data
publisher Swansea University
series International Journal of Population Data Science
issn 2399-4908
publishDate 2017-04-01
description ABSTRACT Objectives We used data from UK-Biobank that were linked with Hospital Episode Statistics and Office for National Statistics to assess the relationship between low-density lipoprotein cholesterol (LDL-C) and atrial fibrillation (AF). In this study, we applied Mendelian randomization in order to find out whether there is a causal effect of LDL-C to AF. Approach We used data from the UK Biobank (~500,000 subjects) which is linked with electronic health records. At baseline (2006-2010), participants from across the UK took part in this project. They have undergone measures, provided blood, urine and saliva samples for future analysis, detailed information about themselves and agreed to have their health followed. Information in relation to the development of atrial fibrillation was derived from a) the enrollment of the participants (self-reported events), b) their hospitalization before and after their recruitment to UK-Biobank (confirmed events from Hospital Episode Statistics) and c) the death certificates [confirmed events from Office for National Statistics]. We also used genetic data from the analyses of the participants’ blood sample that have been stored. We used Mendelian randomization to capture the effect of LDL-C to AF. As instruments, we used a genetic predisposition risk score (GPRs) for LDL-C, which was created as a weighted sum of the 18 most significant SNPs related to LDL-C, as there were documented in Global Lipid Consortium, in 18 out of 22 chromosomes. We ran a logistic regression model, using AF as outcome and GPRs as exposure. Results Our final sample consisted of 144,092 individuals, for which we have valid information for their genetic data. The AF cases in this sample were 3207, most of which were identified from Hospital Episode Statistics (hospitalization of the participants). From the Mendelian randomization study, from our preliminary results, we found a weak positive relationship between GPRs and AF, when we did not adjust for any covariate [OR per one unit increase of GPRs=1.08, 95% CI= (0.95-1.22)] and results remained practically the same when we adjusted for age and sex [OR=1.09, 95% CI= (0.96-1.24 )]. Conclusion We observed a weak positive association between LDL-C and AF in this study. This is the first Mendelian randomization approach that focuses on this relationship. More Mendelian randomization studies should be performed in order to identify the causal effect of LDL-C to AF. The use of electronic health records will facilitate the conduction of similar studies.
url https://ijpds.org/article/view/322
work_keys_str_mv AT michailkatsoulis lowdensitylipoproteincholesterolandatrialfibrillationamendelianrandomizationstudyusingukbiobankdata
AT spirosdenaxas lowdensitylipoproteincholesterolandatrialfibrillationamendelianrandomizationstudyusingukbiobankdata
AT riyazpatel lowdensitylipoproteincholesterolandatrialfibrillationamendelianrandomizationstudyusingukbiobankdata
AT harryhemingway lowdensitylipoproteincholesterolandatrialfibrillationamendelianrandomizationstudyusingukbiobankdata
_version_ 1725459321114853376